Approval · Notice of Compliance 6213 · 2005
ADVANTAGE MULTI 18: Notice of Compliance 6213
Issued January 17, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6213
- Date
- January 17, 2005
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVANTAGE MULTI 18 | 02263513 | Marketed |
Medicinal ingredients
- IMIDACLOPRID 80 MG per 0.8ML
- MOXIDECTIN 8 MG per 0.8ML